Hi Terry,
Whilst im known for my rather contrarian views, I also do my best to explain why.
Whilst you're known for your positive views, you normally explain why. Until this recent post (as above). What outcomes would "dwarf" Cardiocel? Whilst I note HC is a place where people can post almost anything about a stock, I rarely come across a post so sure of amazing success as your recent post.
Would you be so kind to elaborate on what development/research you feel could "dwarf" Cardiocel...? Many a nights I've thought about new developments/progress but certainly didn't have a view that a new product would dwarf Cardiocel.
I hope your post wasn't just unwarranted ramping?
Ann: Admedus to showcase CardioCel at EACTS Annual Meeting, page-63
-
- There are more pages in this discussion • 19 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$18.00 |
Change
0.000(0.00%) |
Mkt cap ! $346.0M | |||
| Open | High | Low | Value | Volume |
| $18.00 | $18.10 | $17.70 | $58.64K | 3.27K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 109 | $18.00 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $18.10 | 700 | 1 |
View Market Depth
| Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
| AVR (ASX) Chart |